Selected research
Industry Research
Hydroxyzine Industry Research Report 2026
Market perspective
The global Hydroxyzine market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Hydroxyzine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Hydroxyzine is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Hydroxyzine is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Hydroxyzine include GSK, Impax Laboratories, N&R Industries, Novartis, Pfizer, Piramal Group (Piramal Healthcare UK Limited), Shanghai Ruizheng Chemical Technology, Teva Pharmaceuticals and Alliance Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Hydroxyzine market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Hydroxyzine Market by Company
GSK
Impax Laboratories
N&R Industries
Novartis
Pfizer
Piramal Group (Piramal Healthcare UK Limited)
Shanghai Ruizheng Chemical Technology
Teva Pharmaceuticals
Alliance Pharma
Hydroxyzine Segment by Type
Tablets
Capsules
Other
Hydroxyzine Segment by Application
Hospitals
Retail Pharmacy
Hydroxyzine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hydroxyzine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Hydroxyzine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hydroxyzine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Hydroxyzine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Hydroxyzine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Hydroxyzine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Tablets
- Capsules
- Other
Applications
- Hospitals
- Retail Pharmacy
Companies covered
- GSK
- Impax Laboratories
- N&R Industries
- Novartis
- Pfizer
- Piramal Group (Piramal Healthcare UK Limited)
- Shanghai Ruizheng Chemical Technology
- Teva Pharmaceuticals
- Alliance Pharma
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Hydroxyzine Market Size (2021-2032)
- 2.2.2 Global Hydroxyzine Sales (2021-2032)
- 2.2.3 Global Hydroxyzine Market Average Price (2021-2032)
- 2.3 Hydroxyzine by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Tablets
- 2.3.3 Capsules
- 2.3.4 Other
- 2.4 Hydroxyzine by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospitals
- 2.4.3 Retail Pharmacy
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Hydroxyzine Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Hydroxyzine Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Hydroxyzine Revenue of Manufacturers (2021-2026)
- 3.4 Global Hydroxyzine Average Price by Manufacturers (2021-2026)
- 3.5 Global Hydroxyzine Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Hydroxyzine, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Hydroxyzine, Product Type & Application
- 3.8 Global Manufacturers of Hydroxyzine, Established Date
- 3.9 Global Hydroxyzine Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 GSK
- 4.1.1 GSK Company Information
- 4.1.2 GSK Business Overview
- 4.1.3 GSK Hydroxyzine Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 GSK Hydroxyzine Product Portfolio
- 4.1.5 GSK Recent Developments
- 4.2 Impax Laboratories
- 4.2.1 Impax Laboratories Company Information
- 4.2.2 Impax Laboratories Business Overview
- 4.2.3 Impax Laboratories Hydroxyzine Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Impax Laboratories Hydroxyzine Product Portfolio
- 4.2.5 Impax Laboratories Recent Developments
- 4.3 N&R Industries
- 4.3.1 N&R Industries Company Information
- 4.3.2 N&R Industries Business Overview
- 4.3.3 N&R Industries Hydroxyzine Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 N&R Industries Hydroxyzine Product Portfolio
- 4.3.5 N&R Industries Recent Developments
- 4.4 Novartis
- 4.4.1 Novartis Company Information
- 4.4.2 Novartis Business Overview
- 4.4.3 Novartis Hydroxyzine Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Novartis Hydroxyzine Product Portfolio
- 4.4.5 Novartis Recent Developments
- 4.5 Pfizer
- 4.5.1 Pfizer Company Information
- 4.5.2 Pfizer Business Overview
- 4.5.3 Pfizer Hydroxyzine Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Pfizer Hydroxyzine Product Portfolio
- 4.5.5 Pfizer Recent Developments
- 4.6 Piramal Group (Piramal Healthcare UK Limited)
- 4.6.1 Piramal Group (Piramal Healthcare UK Limited) Company Information
- 4.6.2 Piramal Group (Piramal Healthcare UK Limited) Business Overview
- 4.6.3 Piramal Group (Piramal Healthcare UK Limited) Hydroxyzine Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Piramal Group (Piramal Healthcare UK Limited) Hydroxyzine Product Portfolio
- 4.6.5 Piramal Group (Piramal Healthcare UK Limited) Recent Developments
- 4.7 Shanghai Ruizheng Chemical Technology
- 4.7.1 Shanghai Ruizheng Chemical Technology Company Information
- 4.7.2 Shanghai Ruizheng Chemical Technology Business Overview
- 4.7.3 Shanghai Ruizheng Chemical Technology Hydroxyzine Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Shanghai Ruizheng Chemical Technology Hydroxyzine Product Portfolio
- 4.7.5 Shanghai Ruizheng Chemical Technology Recent Developments
- 4.8 Teva Pharmaceuticals
- 4.8.1 Teva Pharmaceuticals Company Information
- 4.8.2 Teva Pharmaceuticals Business Overview
- 4.8.3 Teva Pharmaceuticals Hydroxyzine Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Teva Pharmaceuticals Hydroxyzine Product Portfolio
- 4.8.5 Teva Pharmaceuticals Recent Developments
- 4.9 Alliance Pharma
- 4.9.1 Alliance Pharma Company Information
- 4.9.2 Alliance Pharma Business Overview
- 4.9.3 Alliance Pharma Hydroxyzine Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Alliance Pharma Hydroxyzine Product Portfolio
- 4.9.5 Alliance Pharma Recent Developments
5 Global Hydroxyzine Market Scenario by Region
- 5.1 Global Hydroxyzine Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Hydroxyzine Sales by Region: 2021-2032
- 5.2.1 Global Hydroxyzine Sales by Region: 2021-2026
- 5.2.2 Global Hydroxyzine Sales by Region: 2027-2032
- 5.3 Global Hydroxyzine Revenue by Region: 2021-2032
- 5.3.1 Global Hydroxyzine Revenue by Region: 2021-2026
- 5.3.2 Global Hydroxyzine Revenue by Region: 2027-2032
- 5.4 North America Hydroxyzine Market Facts & Figures by Country
- 5.4.1 North America Hydroxyzine Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Hydroxyzine Sales by Country (2021-2032)
- 5.4.3 North America Hydroxyzine Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Hydroxyzine Market Facts & Figures by Country
- 5.5.1 Europe Hydroxyzine Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Hydroxyzine Sales by Country (2021-2032)
- 5.5.3 Europe Hydroxyzine Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Hydroxyzine Market Facts & Figures by Country
- 5.6.1 Asia Pacific Hydroxyzine Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Hydroxyzine Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Hydroxyzine Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Hydroxyzine Market Facts & Figures by Country
- 5.7.1 South America Hydroxyzine Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Hydroxyzine Sales by Country (2021-2032)
- 5.7.3 South America Hydroxyzine Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Hydroxyzine Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Hydroxyzine Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Hydroxyzine Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Hydroxyzine Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Hydroxyzine Sales by Type (2021-2032)
- 6.1.1 Global Hydroxyzine Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Hydroxyzine Sales Market Share by Type (2021-2032)
- 6.2 Global Hydroxyzine Revenue by Type (2021-2032)
- 6.2.1 Global Hydroxyzine Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Hydroxyzine Revenue Market Share by Type (2021-2032)
- 6.3 Global Hydroxyzine Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Hydroxyzine Sales by Application (2021-2032)
- 7.1.1 Global Hydroxyzine Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Hydroxyzine Sales Market Share by Application (2021-2032)
- 7.2 Global Hydroxyzine Revenue by Application (2021-2032)
- 7.2.1 Global Hydroxyzine Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Hydroxyzine Revenue Market Share by Application (2021-2032)
- 7.3 Global Hydroxyzine Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Hydroxyzine Value Chain Analysis
- 8.1.1 Hydroxyzine Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Hydroxyzine Production Mode & Process
- 8.2 Hydroxyzine Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Hydroxyzine Distributors
- 8.2.3 Hydroxyzine Customers
9 Global Hydroxyzine Analyzing Market Dynamics
- 9.1 Hydroxyzine Industry Trends
- 9.2 Hydroxyzine Industry Drivers
- 9.3 Hydroxyzine Industry Opportunities and Challenges
- 9.4 Hydroxyzine Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst